Learning Objectives: 

1.) To review the role of belimumab in the treatment of lupus. 

2.) To discuss the potential role of belimumab in the treatment of lupus nephritis, the most common severe manifestation of lupus, based on the attached article. 

Disclosures:

Recent winner of the 2020 ACR Convergence Thieves' Market!!!!!!! 

- Advisory boards for AstraZeneca, Exagen, Eli Lilly, and Pfizer.

- Receives grant funding from Pfizer, Exagen, and the NIH.

- Has participated in clinical trials with AstraZeneca, Janssen, GSK, HGS, Xencor, BMS, Eli Lilly, and Gilead. 

CME Code: FAPHEL

Location: virtual (by WebEx only)
Directions: If you are having trouble accessing WebEx, please contact Isaac Smith at [email protected]. 

Streaming: Yes, via WebEx. Link:  https://dukemed.webex.com/meet/is120

Meeting Number/Access Code: 470 543 135  (you will not need this if you use link above)

Call-in number: 1-650-479-3207